⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
Compassionate useMitochondrial Peptide

Compound 61655

Formula Pending

Molecular Mass
N/A
CAS Registry
AUTO-061655
Risk Class
LOW
Last Audit
May 27, 2108

Research Abstract

Mitochondrial Peptide candidate engineered for metabolic regulation initiatives with automated dossier coverage.

Compound 61655 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.

The dossier currently sits in compassionate use with a low risk rating, meaning it is cleared for baseline monitoring protocols.

Supply records cite CAS AUTO-061655 with updates logged 2108-05-27.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

Metabolic regulationCardiometabolic recovery

Nomenclature

CX-61655Mitochondrial Peptide Program 61655

Reference Material

  1. [1] Anubis Compound Registry • CAS AUTO-061655
  2. [2] Operations Pulse • Mitochondrial Peptide innovation track
  3. [3] Risk Governance Ledger • LOW clearance for COMPOUND-61655